Sahil Khanna, Matthew Sims, Thomas J. Louie, Monika Fischer, Kerry LaPlante, Jessica Allegretti, . . . Mark H. Wilcox. (2022). SER-109: An Oral Investigational Microbiome Therapeutic for Patients with Recurrent <i>Clostridioides difficile</i> Infection (rCDI). MDPI AG.
Chicago Style (17th ed.) CitationSahil Khanna, et al. SER-109: An Oral Investigational Microbiome Therapeutic for Patients with Recurrent <i>Clostridioides Difficile</i> Infection (rCDI). MDPI AG, 2022.
MLA (9th ed.) CitationSahil Khanna, et al. SER-109: An Oral Investigational Microbiome Therapeutic for Patients with Recurrent <i>Clostridioides Difficile</i> Infection (rCDI). MDPI AG, 2022.
Warning: These citations may not always be 100% accurate.